Both subjects had viral RNA shedding levels 25), chronic lung disease (including asthma), chronic kidney disease, current smoker, immunosuppressive disease or immunosuppressive treatment, cardiovascular disease, hypertension, sickle cell disease, neurodevelopmental disorders, active cancer, medically-related technological dependence, or were 60 years of age and older regardless of comorbidities
Its a triple-agonist, meaning it targets three different receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and the glucagon receptor
2025 Dec 30:114591
(More information) Overall, early observational studies have found either null or inverse (protective) associations between selenium exposure and risk of site-specific cancers